<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39457280</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Life after Lockdown: An Exploratory Qualitative Study of Behaviors and Impacts of Avoiding COVID-19 in Individuals at High Risk of Severe COVID-19 and Their Caregivers.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1307</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph21101307</ELocationID><Abstract><AbstractText>This exploratory qualitative study involved semi-structured interviews with adults and caregivers of adults at high risk of severe COVID-19, addressing current COVID-19 avoidance and protective behaviors and how these behaviors impacted their lives. Results were interpreted in a separate think tank session. Insights were developed into a conceptual model of COVID-19 avoidance and protective behaviors and the associated impacts on health-related quality of life and overall functioning. Data were interpreted using a hybrid inductive and deductive thematic analysis. Twelve high-risk individuals and two caregivers were interviewed across four focus groups (April-July 2022). Major behavioral themes included physical distancing, physical and medical protection, quality of support services and networks, and information to make decisions. Major impacts included family, social, and emotional functioning; work and finances; and healthcare access. The final conceptual model comprised 13 behaviors to avoid COVID-19 categorized within four themes, and 13 impacts within five themes. Individuals at high risk of severe COVID-19 and their caregivers continue practicing COVID-19 avoidance behaviors post-lockdown and feel left behind by the general population. Our conceptual model may be used to inform health authorities and other governing bodies' decisions in executing strategies aimed at improving these individuals' lives.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maia</LastName><ForeName>Tiago</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Patient Centered Solutions, IQVIA, 2740-266 Porto Salvo, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokota</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Epidemiology &amp; Pharmacovigilance, P95, 3001 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnetorp</LastName><ForeName>Sofie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Health Economics &amp; Payer Evidence, Vaccines &amp; Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Patient representative, Vale of Glamorgan, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rae-Garwood</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Patient representative, Glendale, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Settergren</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0002-2734-0454</Identifier><AffiliationInfo><Affiliation>Global Evidence Portfolio Delivery, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckerd</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Global Patient Engagement R&amp;I, AstraZeneca, Wilmington, DE 19850, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6259-0390</Identifier><AffiliationInfo><Affiliation>Patient Centered Solutions, IQVIA, 92400 Courbevoie, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Patient Centered Science, Vaccine &amp; Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, 431 83 Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>0</GrantID><Agency>AstraZeneca</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">conceptual model</Keyword><Keyword MajorTopicYN="N">focus group</Keyword><Keyword MajorTopicYN="N">immunocompromised</Keyword><Keyword MajorTopicYN="N">physical distancing</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>Tiago Maia is an employee of IQVIA, the research organization contracted to conduct this study. Paul Willams was employed by IQVIA, which was under contract with AstraZeneca at the time of the study, and is now employed by AstraZeneca. Renata Yokota is an employee of P95, under a contract with AstraZeneca. Sofie Arnetorp and Gabriella Settergren are employees of, and own stocks or shares in, AstraZeneca. Marie Eckerd was an employee of AstraZeneca at the time of the study but is now retired from AstraZeneca. Gail Rae-Garwood is a patient advisor to both AstraZeneca and Otsuka. Joanne Smith and Gail Rae-Garwood received honoraria for participating in the &amp;lsquo;think tank&amp;rsquo; session of the current study, but did not receive payment for their time as co-authors on the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39457280</ArticleId><ArticleId IdType="pmc">PMC11507298</ArticleId><ArticleId IdType="doi">10.3390/ijerph21101307</ArticleId><ArticleId IdType="pii">ijerph21101307</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fung M., Babik J.M. COVID-19 in immunocompromised hosts: What we know so far. Clin. Infect. Dis. 2021;72:340–350. doi: 10.1093/cid/ciaa863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa863</ArticleId><ArticleId IdType="pmc">PMC7337668</ArticleId><ArticleId IdType="pubmed">33501974</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson E.J., Walker A.J., Bhaskaran K., Bacon S., Bates C., Morton C.E., Curtis H.J., Mehrkar A., Evans D., Inglesby P., et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoun J., Brown D.J., Jones D.J.W., Sangala N.C., Lewis R.J., Shepherd A.I., McNarry M.A., Mackintosh K.A., Mason L., Corbett J., et al. Understanding the impact of initial COVID-19 restrictions on physical activity, wellbeing and quality of life in shielding adults with end-stage renal disease in the United Kingdom dialysing at home versus in-centre and their experiences with telemedicine. Int. J. Environ. Res. Public Health. 2021;18:3144. doi: 10.3390/ijerph18063144.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18063144</ArticleId><ArticleId IdType="pmc">PMC8002886</ArticleId><ArticleId IdType="pubmed">33803708</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng P., Hao Y., Liu Y., Chen S., Wang Y., Yang Q., Wang X., Li M., Wang Y., He L., et al. The prevalence and risk factors of mental problems in medical students during COVID-19 pandemic: A systematic review and meta-analysis. J. Affect. Disord. 2023;321:167–181. doi: 10.1016/j.jad.2022.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.10.040</ArticleId><ArticleId IdType="pmc">PMC9613786</ArticleId><ArticleId IdType="pubmed">36341802</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Sanguino C., Ausin B., Castellanos M.A., Saiz J., Lopez-Gomez A., Ugidos C., Munoz M. Mental health consequences during the initial stage of the 2020 coronavirus pandemic (COVID-19) in Spain. Brain Behav. Immun. 2020;87:172–176. doi: 10.1016/j.bbi.2020.05.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.040</ArticleId><ArticleId IdType="pmc">PMC7219372</ArticleId><ArticleId IdType="pubmed">32405150</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi L., Daniels J. Forsaken but Engaged: An Inquiry into the Psychological Aspects of COVID-19, Mental Health, and Political Engagement of Immunocompromised People.  [(accessed on 26 July 2023)].  Available online:  https://www.liverpool.ac.uk/humanities-and-social-sciences/research/coronavirus-research/forgotten-forsaken/</Citation></Reference><Reference><Citation>Luo M., Guo L., Yu M., Jiang W., Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public—A systematic review and meta-analysis. Psychiatry Res. 2020;291:113190. doi: 10.1016/j.psychres.2020.113190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113190</ArticleId><ArticleId IdType="pmc">PMC7276119</ArticleId><ArticleId IdType="pubmed">32563745</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler J., Bath M., Blana D., Ball W., Beech N., Black C., Osler G., Peytrignet S., Rzewuska M., Wilde K., et al. The clinically extremely vulnerable to COVID: Identification and changes in healthcare while self-isolating (shielding) during the coronavirus pandemic. Int. J. Popul. Data Sci. 2022;7:1897. doi: 10.23889/ijpds.v7i3.1897.</Citation><ArticleIdList><ArticleId IdType="doi">10.23889/ijpds.v7i3.1897</ArticleId></ArticleIdList></Reference><Reference><Citation>Westcott K.A., Wilkins F., Chancellor A., Anderson A., Doe S., Echevarria C., Bourke S.J. The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis. Future Healthc. J. 2021;8:e47–e49. doi: 10.7861/fhj.2020-0205.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/fhj.2020-0205</ArticleId><ArticleId IdType="pmc">PMC8004337</ArticleId><ArticleId IdType="pubmed">33791475</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellafiore F., Arrigoni C., Nania T., Caruso R., Baroni I., Vangone I., Russo S., Barello S. The impact of COVID-19 pandemic on family caregivers’ mental health: A rapid systematic review of the current evidence. Acta Biomed. 2022;93:e2022154. doi: 10.23750/abm.v93iS2.12979.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v93iS2.12979</ArticleId><ArticleId IdType="pmc">PMC9534216</ArticleId><ArticleId IdType="pubmed">35545977</ArticleId></ArticleIdList></Reference><Reference><Citation>The Prime Minister’s Office of the United Kingdom Government  PM Statement at Covid Press Conference: 21 February 2022.  [(accessed on 26 July 2023)]; Available online:  https://www.gov.uk/government/speeches/pm-statement-at-covid-press-conference-21-february-2022.</Citation></Reference><Reference><Citation>United Nations  WHO Chief Declares End to COVID-19 as a Global Health Emergency.  [(accessed on 26 May 2023)].  Available online:  https://news.un.org/en/story/2023/05/1136367#:~:text=WHO%20chief%20declares%20end%20to%20COVID%2D19%20as%20a%20global%20health%20emergency,-5%20May%202023&amp;text=The%20head%20of%20the%20UN,no%20longer%20a%20global%20threat.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  End of the Federal COVID-19 Public Health Emergency (PHE) Declaration.  [(accessed on 26 July 2023)]; Available online:  https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/your-health/end-of-phe.html.</Citation></Reference><Reference><Citation>Office for National Statistics  Coronavirus and Clinically Extremely Vulnerable (CEV) People in England: 4 April to 23 April 2022.  [(accessed on 11 July 2023)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronavirusandclinicallyextremelyvulnerablepeopleinengland/4aprilto23april2022.</Citation></Reference><Reference><Citation>Pander J., Beekman-Hendriks W., Coolen N., van de Flier V., Senster J., Rovers C.P. No more government-imposed societal-level COVID-19 control measures but still significant self-experienced burden for severely immunocompromised individuals—A cross-sectional survey in the Netherlands. Prev. Med. Rep. 2024;45:102827. doi: 10.1016/j.pmedr.2024.102827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmedr.2024.102827</ArticleId><ArticleId IdType="pmc">PMC11304848</ArticleId><ArticleId IdType="pubmed">39114410</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Preventing Respiratory Viruses.  [(accessed on 28 August 2024)]; Available online:  https://www.cdc.gov/respiratory-viruses/prevention/index.html.</Citation></Reference><Reference><Citation>GOV.UK  COVID-19: Guidance for People Whose Immune System Means They Are at Higher Risk.  [(accessed on 28 August 2024)]; Available online:  https://www.gov.uk/government/publications/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk.</Citation></Reference><Reference><Citation>Brien P., Keep M. Public Spending during the COVID-19 Pandemic.  [(accessed on 7 March 2024)].  Available online:  https://researchbriefings.files.parliament.uk/documents/CBP-9309/CBP-9309.pdf.</Citation></Reference><Reference><Citation>Lo Iacono S., Przepiorka W., Buskens V., Corten R., van de Rijt A. COVID-19 vulnerability and perceived norm violations predict loss of social trust: A pre-post study. Soc. Sci. Med. 2021;291:114513. doi: 10.1016/j.socscimed.2021.114513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2021.114513</ArticleId><ArticleId IdType="pmc">PMC8553419</ArticleId><ArticleId IdType="pubmed">34717284</ArticleId></ArticleIdList></Reference><Reference><Citation>van Tilburg T.G., Steinmetz S., Stolte E., van der Roest H., de Vries D.H. Loneliness and mental health during the COVID-19 pandemic: A study among Dutch older adults. J. Gerontol. B Psychol. Sci. Soc. Sci. 2021;76:e249–e255. doi: 10.1093/geronb/gbaa111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbaa111</ArticleId><ArticleId IdType="pmc">PMC7454922</ArticleId><ArticleId IdType="pubmed">32756931</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogundipe H., Buowari D.Y., Dosunmu K. Psychosocial impact of the implementation of COVID-19 protocols. West. Afr. J. Med. 2023;40:227–231.</Citation><ArticleIdList><ArticleId IdType="pubmed">36861502</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandi-Perumal S.R., Zaki N.F.W., Qasim M., Elsayed Morsy N., Manzar M.D., BaHammam A.S., Jahrami H., Ramasubramanian C., Karthikeyan R., Supasitthumrong T., et al. Neuropsychiatric consequences of COVID-19 pandemic: A synthetic review from a global perspective. Alpha Psychiatry. 2022;23:144–154. doi: 10.5152/alphapsychiatry.2022.21783.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/alphapsychiatry.2022.21783</ArticleId><ArticleId IdType="pmc">PMC9590656</ArticleId><ArticleId IdType="pubmed">36425743</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke V., Braun V. Successful Qualitative Research: A Practical Guide for Beginners. SAGE Publications Ltd; London, UK: 2013. p. 400.</Citation></Reference><Reference><Citation>Fugard A.J.B., Potts H.W.W. Supporting thinking on sample sizes for thematic analyses: A quantitative tool. Int. J. Soc. Res. Methodol. 2015;18:669–684. doi: 10.1080/13645579.2015.1005453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13645579.2015.1005453</ArticleId></ArticleIdList></Reference><Reference><Citation>Guest G., Namey E., O’Regan A., Godwin C., Taylor J. Comparing Interview and Focus Group Data Collected in Person and Online [Internet] Patient-Centered Outcomes Research Institute (PCORI); Washington, DC, USA: 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">36701499</ArticleId></ArticleIdList></Reference><Reference><Citation>Radics M., Christidis P. Impact of the COVID-19 Pandemic on Mobility in Spain. Publications Office of the European Union; Luxembourg: 2022.</Citation></Reference><Reference><Citation>Canadian Institute for Health Information  Canadian COVID-19 Intervention Timeline.  [(accessed on 6 September 2024)].  Available online:  https://www.cihi.ca/en/canadian-covid-19-intervention-timeline.</Citation></Reference><Reference><Citation>US Department of Defense  Coronovirus: Timeline.  [(accessed on 6 September 2024)]; Available online:  https://www.defense.gov/Spotlights/Coronavirus-DOD-Response/Timeline/</Citation></Reference><Reference><Citation>Tanne J.H. COVID-19: Mask mandate is struck down although US cases are rising. BMJ. 2022;377:o998. doi: 10.1136/bmj.o998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o998</ArticleId><ArticleId IdType="pubmed">35440431</ArticleId></ArticleIdList></Reference><Reference><Citation>Fereday J., Muir-Cochrane E. Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive coding and theme development. Int. J. Qual. Methods. 2006;5:80–92. doi: 10.1177/160940690600500107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/160940690600500107</ArticleId></ArticleIdList></Reference><Reference><Citation>Elo S., Kyngas H. The qualitative content analysis process. J. Adv. Nurs. 2008;62:107–115. doi: 10.1111/j.1365-2648.2007.04569.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2007.04569.x</ArticleId><ArticleId IdType="pubmed">18352969</ArticleId></ArticleIdList></Reference><Reference><Citation>Walewski J.L., Donovan D., Nori M. How many zebras are there, and where are they hiding in medical literature? A literature review of publications on rare diseases. Expert Opin. Orphan Drugs. 2019;7:513–519. doi: 10.1080/21678707.2019.1684260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678707.2019.1684260</ArticleId></ArticleIdList></Reference><Reference><Citation>Bytyci J., Ying Y., Lee L.Y.W. Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: A systematic review. Immun. Inflamm. Dis. 2024;12:e1259. doi: 10.1002/iid3.1259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.1259</ArticleId><ArticleId IdType="pmc">PMC11044684</ArticleId><ArticleId IdType="pubmed">38661301</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip K.E.J., Lonergan B., Cumella A., Farrington-Douglas J., Laffan M., Hopkinson N.S. COVID-19 related concerns of people with long-term respiratory conditions: A qualitative study. BMC Pulm. Med. 2020;20:319. doi: 10.1186/s12890-020-01363-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-01363-9</ArticleId><ArticleId IdType="pmc">PMC7724437</ArticleId><ArticleId IdType="pubmed">33298023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitpolprasert C., Anand T., Phanuphak N., Reiss P., Ananworanich J., Peay H.L. A qualitative study of the impact of coronavirus disease (COVID-19) on psychological and financial wellbeing and engagement in care among men who have sex with men living with HIV in Thailand. HIV Med. 2022;23:227–236. doi: 10.1111/hiv.13190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hiv.13190</ArticleId><ArticleId IdType="pmc">PMC8653254</ArticleId><ArticleId IdType="pubmed">34634181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerstein S., Konig C., Dreisorner T., Frey A. Effects of COVID-19-related school closures on student achievement-a systematic review. Front. Psychol. 2021;12:746289. doi: 10.3389/fpsyg.2021.746289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.746289</ArticleId><ArticleId IdType="pmc">PMC8481663</ArticleId><ArticleId IdType="pubmed">34603162</ArticleId></ArticleIdList></Reference><Reference><Citation>Manca R., De Marco M., Colston A., Raymont V., Amin J., Davies R., Kumar P., Russell G., Blackburn D.J., Venneri A. The impact of social isolation due to the COVID-19 pandemic on patients with dementia and caregivers. Acta Neuropsychiatr. 2022;34:276–281. doi: 10.1017/neu.2022.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/neu.2022.12</ArticleId><ArticleId IdType="pubmed">35369891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd A., Arnetorp S., Marcus J., Yokota R.T.C., Herring T.A., Powell P.A., Rohay J., Severens J.L., Venkatesan S., Williams P., et al. PCR226 Health related quality of life and health utility values across different levels of physically distancing behaviors to avoid COVID-19 in immunocompromised adults—The Eagle Study. Value Health. 2023;26:S492. doi: 10.1016/j.jval.2023.09.2663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2023.09.2663</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell P.A., Williams P., Herring T.A., Venkatesan S., Arnetorp S., Lloyd A., Marcus J., Ouwens M., Rohay J., Severens J.L., et al. PCR172 Physical distancing to avoid COVID-19 and the association with humanistic burden in immunocompromised adults—The Eagle Study. Value Health. 2023;26:S482. doi: 10.1016/j.jval.2023.09.2610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2023.09.2610</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams P., Herring T.A., Yokota R.T.C., Maia T., Venkatesan S., Marcus J.C., Settergren G., Arnetorp S., Lloyd A., Severens J.L., et al. The association between physical distancing behaviors to avoid COVID-19 and health-related quality of life in immunocompromised and nonimmunocompromised individuals: Patient-informed protocol for the observational, cross-sectional EAGLE Study. JMIR Res. Protoc. 2024;13:e52643. doi: 10.2196/52643.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/52643</ArticleId><ArticleId IdType="pmc">PMC11350303</ArticleId><ArticleId IdType="pubmed">39137022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>